DNA base editors |
BE1 |
(APOBEC1–XTEN–dCas9): Composed of a cytidine deaminase enzyme APOBEC1 (from rats) linked to a catalytically dead Cas9 (dcas9) by a 16 amino acid XTEN linker |
C to T |
−17 to −13 |
Komor et al. (2016) |
BE2 |
(APOBEC–XTEN–dCas9–UGI): UGI is fused to the C terminus of BE1. |
C to T |
−17 to −13 |
Komor et al. (2016) |
BE3 |
(APOBEC–XTEN–Cas9n–GI): rAPOBEC1 fused to the N terminus of nickase cas9 D10A through a 16‐amino acid XTEN linker and a UGI fused to the C terminus by a 4‐amino acid linker |
C to T |
−16 to −12 |
Komor et al. (2016) |
YEE‐BE3 |
(W90Y+R126E+R132E): triple mutant |
C to T |
−15 to −13 |
Kim et al. (2017) |
BE4 |
Composed of rAPOBEC1 fused to Cas9D10A through a 32‐aa linker and two UGI molecules are linked to both C and N terminal of Cas9 nickase by a 9‐aa linker. |
C to T |
−17 to −13 |
Komor et al. (2017) |
SaBE4‐GAM |
Gam protein fused to Staphylococcus aureus Cas9‐derived BE4 |
C to T |
−19 to −9 |
Komor et al. (2017) |
Target‐AID |
Composed of nickase Cas9D10A and a cytidine deaminase pmCDA1 (from sea lamprey) |
C to T |
−19 to −15 |
Nishida et al. (2016) |
TAM |
dCas9 is fused to human AID; co‐expressed with UGI |
C to T |
−16 to −12 |
Ma et al. (2016) |
CRISPR‐X |
dCas9 is used to target a hyperactive AID variant to induce localized, diverse point mutations. The sgRNA backbone contains two MS2 RNA hairpins that each recruit two MS2 proteins fused to AID |
C to T |
−50 to +50 |
Hess et al. (2016) |
ABE |
TadA is fused to a catalytically impaired CRISPR/Cas9 mutant |
A to G |
−17 to −14 |
Gaudelli et al. (2017) |
RNA base editor |
ADAR |
Catalytically inactive Cas13 (dCas13) is fused to a naturally occurring ADAR (adenosine deaminase acting on RNA) |
A to 1 |
−50 to +50 |
Cox et al. (2017) |